Table 2 Genetic characteristics of the T2DM patients and control groups
Variables | Patients (n = 75) | Controls (n = 63) | OR (95% CI) | P-value |
|---|---|---|---|---|
Genotypes | ||||
E/E | 29 (38.7%) | 18 (28.6%) | Reference | |
E/K | 34 (45.3%) | 42 (66.6%) | 0.502 (0.239–1.055) | 0.067 |
K/K | 12 (16%) | 3 (4.8%) | 2.483 (0.615–10.02) | 0.192 |
Dominant model | ||||
E/E | 29 (38.7%) | 18 (28.6%) | Reference | |
E/K + K/K | 46 (61.3%) | 45 (71.4%) | 0.634 (0.31–1.3) | 0.213 |
Recessive model | ||||
E/E+ E/K | 63 (84%) | 60 (95.2%) | Reference | |
K/K | 12 (16%) | 3 (4.8%) | 3.81 (1.024–14.17) | 0.035 |
Alleles | ||||
E | 92 (61.3%) | 78 (61.9%) | Reference | |
K | 58 (38.7%) | 48 (38.1%) | 1.024 (0.629–1.667) | 0.923 |